CTRI/2022/12/048219已完成4 期
â??Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of application on healthy human all skin typesâ?¿.
Vasu Health Care0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects who are willing to participate in the study and sign the informed consent document and comply with the trial procedure.
- •2.Healthy Men & women volunteers are chosen in ratio of 1:1 aged > 35 and < 60 years.
- •3.Having healthy skin on test area as assessed by dermatological examination and donâ??t have history of allergy.
排除标准
- •1.Pregnant/nursing mothers.
- •2.Scars, excessive terminal hair, or tattoos on the studied area.
- •3.Dermatological infection/pathology on level of studied area.
- •4.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material)
- •5.Chronic illness which may influence the outcome of the study.
研究者
相似试验
已完成
4 期
Safety evaluation of test products on healthy skin typeCTRI/2023/03/050796Dabur India Limited24
已完成
不适用
Safety testing of cosmetic products by patch testCTRI/2021/12/038826Arbro pharmaceutical Pvt Ltd24
已完成
不适用
Safety evaluation of cosmetic products by patch testCTRI/2022/02/040338Arbro pharmaceutical Pvt Ltd24
已完成
不适用
Safety testing of cosmetic products by PIPT(Primary Irritation Patch Test)CTRI/2022/02/039947Arbro pharmaceutical Pvt Ltd24
尚未招募
Unknown
To check dermatological safety of test products by 24 hours patch test on adult healthy human subjectsCTRI/2024/06/069652Kayura Effect LLP